|
See related Ferriprox information |
|
|
|
Manufacturer |
Apotex |
|
Distributor |
Hong Kong: Hind Wing |
|
Contents |
Deferiprone |
|
Indications |
Chronic Fe overload in transfusional haemosiderosis esp in thalassaemia major. Idiopathic haemochromatosis, Fe poisoning. |
|
Dosage |
25 mg/kg body wt tds. |
|
Administration |
May be taken with or without food |
|
Contraindications |
Neutropenia, agranulocytosis. Pregnancy & lactation. |
|
Special Precautions |
Monitor neutrophil counts wkly. Interrupt therapy if patient develops an infection. |
|
Adverse Drug Reactions |
Reddish discolouration of the urine, nausea, abdominal pain, vomiting. Rarely, neutropenia, agranulocytosis.
View ADR Monitoring Form |
|
ATC Classification |
V03AC02 - deferiprone ; Belongs to the class of iron chelating agents. Used in iron overload. |
|
Presentation/Packing |
|
Form |
Packing |
Photo |
|
Ferriprox tablet |
|
|
Ferriprox oral solution |
|
Ferriprox 100 mg/1 mL x 500 mL |
|
|
|
Manufacturer: |
Apotex |
|
Distributor: |
Hong Kong: Hind Wing |
|
|
|
|
|
